메뉴 건너뛰기




Volumn 26, Issue 7, 2010, Pages 1621-1628

Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: A pooled analysis of treat-to-target trials

Author keywords

Blood glucose; Insulin aspart; Insulin detemir; Insulin glargine; Pooled analysis; Type 2 diabetes

Indexed keywords

BIPHASIC INSULIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; ANTIDIABETIC AGENT; DRUG COMBINATION; DRUG DOSAGE FORM; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

EID: 77953601896     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.485087     Document Type: Article
Times cited : (22)

References (16)
  • 1
    • 77649091668 scopus 로고    scopus 로고
    • AACE diabetes mellitus clinical practice guidelines task force
    • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus
    • Rodbard HW, Blonde L, Braithwaite SS, et al. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl. 1):1-68.
    • (2007) Endocr Pract , vol.13 , Issue.SUPPL. 1 , pp. 1-68
    • Rodbard, H.W.1    Blonde, L.2    Braithwaite, S.S.3
  • 2
    • 60449089649 scopus 로고    scopus 로고
    • Medical management of hyper-glycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • American Diabetes Association; European Association for Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyper-glycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 3
    • 35548947584 scopus 로고    scopus 로고
    • Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
    • 4-T Study Group
    • Holman RR, Thorne KI, Farmer AJ, et al. 4-T Study Group. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007;357:1716-1730
    • (2007) N Engl J Med , vol.357 , pp. 1716-1730
    • Holman, R.R.1    Thorne, K.I.2    Farmer, A.J.3
  • 4
    • 58149177356 scopus 로고    scopus 로고
    • Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin Plus Oral agents)
    • Raskin P, Matfin G, Schwartz SL, et al. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin Plus Oral agents). Diabet Obes Metab 2009;11:27-32.
    • (2009) Diabet Obes Metab , vol.11 , pp. 27-32
    • Raskin, P.1    Matfin, G.2    Schwartz, S.L.3
  • 5
    • 39049105019 scopus 로고    scopus 로고
    • A randomized 52-week treat-to-target trial comparing insulin detemir with insulin glargine when added to glucose-lowering drugs in insulin-naive people with type 2 diabetes
    • Rosenstock J, Davies M, Home PD, et al. A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when added to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia 2008;51:408-416
    • (2008) Diabetologia , vol.51 , pp. 408-416
    • Rosenstock, J.1    Davies, M.2    Home, P.D.3
  • 6
    • 33746391488 scopus 로고    scopus 로고
    • A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
    • Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 2006;29:1269-1274
    • (2006) Diabetes Care , vol.29 , pp. 1269-1274
    • Hermansen, K.1    Davies, M.2    Derezinski, T.3
  • 7
    • 33646014162 scopus 로고    scopus 로고
    • Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
    • for the 1-2-3 study group
    • Garber A, Wahlen J, Wahl T, et al. for the 1-2-3 study group. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006;8:58-66.
    • (2006) Diabetes Obes Metab , vol.8 , pp. 58-66
    • Garber, A.1    Wahlen, J.2    Wahl, T.3
  • 8
    • 33845236398 scopus 로고    scopus 로고
    • Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    • Philis-Tsimikas A, Charpentier G, Clauson P, et al. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006;28:1569-1581
    • (2006) Clin Ther , vol.28 , pp. 1569-1581
    • Philis-Tsimikas, A.1    Charpentier, G.2    Clauson, P.3
  • 9
    • 12844265257 scopus 로고    scopus 로고
    • Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
    • INITIATE study group
    • Raskin P, Allen E, Hollander P, et al. for the INITIATE study group. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28:260-265
    • (2005) Diabetes Care , vol.28 , pp. 260-265
    • Raskin, P.1    Allen, E.2    Hollander, P.3
  • 10
    • 12844276465 scopus 로고    scopus 로고
    • Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
    • Janka HU, Plewe G, Riddle MC, et al. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005;28:254-259
    • (2005) Diabetes Care , vol.28 , pp. 254-259
    • Janka, H.U.1    Plewe, G.2    Riddle, M.C.3
  • 11
    • 0242269000 scopus 로고    scopus 로고
    • The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • Insulin Glargine 4002 Study Investigators
    • Riddle MC, Rosenstock J, Gerich J. Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 12
    • 37449017989 scopus 로고    scopus 로고
    • Mealtime 50/50 basal\+ prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA 1c and pre-and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison
    • Robbins DC, Beisswenger PJ, Ceriello A, et al. Mealtime 50/50 basal\+ prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre-and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Clin Ther 2007;29:2349-2364
    • (2007) Clin Ther , vol.29 , pp. 2349-2364
    • Robbins, D.C.1    Beisswenger, P.J.2    Ceriello, A.3
  • 13
    • 14844360413 scopus 로고    scopus 로고
    • Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
    • Lispro Mixture-Glargine Study Group
    • Malone JK, Kerr LF, Campaigne BN, et al. Lispro Mixture-Glargine Study Group. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther 2004;26:2034-2044
    • (2004) Clin Ther , vol.26 , pp. 2034-2044
    • Malone, J.K.1    Kerr, L.F.2    Campaigne, B.N.3
  • 14
    • 17144389381 scopus 로고    scopus 로고
    • Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes
    • Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabet Med 2005;22:374-381
    • (2005) Diabet Med , vol.22 , pp. 374-381
    • Malone, J.K.1    Bai, S.2    Campaigne, B.N.3
  • 15
    • 33746893121 scopus 로고    scopus 로고
    • A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents
    • Jacober SJ, Scism-Bacon JL, Zagar AJ. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents. Diabetes Obes Metab 2006;8: 448-455
    • (2006) Diabetes Obes Metab , vol.8 , pp. 448-455
    • Jacober, S.J.1    Scism-Bacon, J.L.2    Zagar, A.J.3
  • 16
    • 33748263029 scopus 로고    scopus 로고
    • Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
    • Kazda C, Hü lstrunk H, Helsberg K, et al. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy. J Diabetes Complications 2006;20: 145-152
    • (2006) J Diabetes Complications , vol.20 , pp. 145-152
    • Kazda, C.1    Hülstrunk, H.2    Helsberg, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.